期刊文献+

人PD-L2基因克隆及其在大肠杆菌中的表达 被引量:1

Gene cloning of human PD-L2 gene and its expression in Escherichia coli
下载PDF
导出
摘要 目的 克隆人PD L2基因并构建PD L2胞外区的原核表达载体 ,在大肠杆菌中进行表达。方法 以RT PCR方法从活化的人外周血单个核细胞总RNA中克隆PD L2基因的cDNA ,构建PD L2胞外区的原核表达载体 ,在大肠杆菌BL2 1(ED3)中进行表达并鉴定。结果 克隆到PD L2基因cDNA编码区全长序列 ,经DNA测序证明其与已报道的序列一致。进而构建了PD L2胞外区的原核表达载体 ,并在大肠杆菌表达 ,免疫印迹分析表明在IPTG诱导后表达PD L2胞外区蛋白 ,相对分子质量Mr 为 2 2 0 0 0 ,与理论值大小相符。结论 成功克隆PD L2基因 ,其胞外区蛋白在大肠杆菌中获得表达 ,为进一步研究PD L2功能提供了条件。 Objective To clone the human PD-L2 gene and to construct a prokaryotic expression vector for the extracellular domain of PD-L2. Methods The cDNA of human PD-L2 gene was cloned from the total RNA of activated human peripheral blood mononuclear cells by RT-PCR. The prokaryotic expression vector for the extracellular domain of PD-L2 was constructed and its expression in Escherichia coli (E. coli) was determined. Results The full-length coding sequence of PD-L2 gene was cloned and confirmed by DNA sequencing, which was identical to the published gene. The prokaryotic expression vector for the extracellular domain of PD-L2 was then constructed. The recombinant protein was expressed in E. coli after the IPTG induction and identified by Western blotting. The recombinant protein had a molecular weight of 22 000, which was consistent with theoretical calculation. Conclusion The gene of PD-L2 is successfully cloned and the extracellular domain protein of the PD-L2 is expressed in E. coli, which provides a basis for the further study of the function of PD-L2.
出处 《免疫学杂志》 CAS CSCD 北大核心 2004年第5期346-349,共4页 Immunological Journal
基金 国家自然科学基金重点项目 (30 2 30 350 ) 国家自然科学基金项目 (30 371 651 ) 国家重点基础研究发展规划 (973)项目 (G2 0 0 0 570 0 6)资助
关键词 PD-L2 基因克隆 大肠杆菌 重组蛋白 PD-L2 Gene cloning Escherichia coli Recombinant protein
  • 相关文献

参考文献8

  • 1[1]Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy [J]. Ann Rev Immunol, 1989, 7: 445-480.
  • 2[2]Pardoll DM. Spinning molecular immunology into successful immunotherapy [J]. Nat Rev Immunol, 2002, 2(4):227-238.
  • 3[3]Carreno BM, Collins M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J]. Ann Rev Immunol, 2002, 20: 29-53.
  • 4[4]Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation [J]. J Exp Med, 1995,182 (2): 459 - 465.
  • 5[5]Latchman Y, Wood CR, Chernova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation [ J ]. Nat Immunol, 2001, 2(3): 261- 268.
  • 6[6]Tseng SY, Otsuji M, Gorski K, et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells [J]. J Exp Med, 2001, 193(7): 839- 845.
  • 7[7]Wang S, Bajorath J, Flies DB, et al. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction [ J ]. J Exp Med,2003, 197(9): 1 083 - 1 091.
  • 8范慧,莫晓宁,曹丽,宋泉声,黄大无,马大龙.趋化因子新变异体MPIF-1β重组蛋白的纯化和活性分析[J].免疫学杂志,2002,18(4):311-314. 被引量:1

二级参考文献3

同被引文献11

  • 1Quezada SA, Jarvinen LZ, Lind EF, et al. CD40/CD154 interactions at the interface of tolerance and immunity [ J ].Annu Rev Immunol, 2004, 22: 307- 328.
  • 2Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation [J]. J Biomed Sci, 2004, 11 (4): 426-438.
  • 3Rossi G, Sarkar J, Scandella D. Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A [ J ]. Blood, 2001, 97 (9):2 750 - 2 757.
  • 4Homann D, Jahreis A, Wolfe T, et al. CD 4 0 L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells [J]. Immunity, 2002, 16 (3): 403-415.
  • 5Wang X, Huang W, Mihara M, et al. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus Erythematosus [ J]. J Immunol, 2002,168 (4): 2 046- 2 053.
  • 6Jin YZ, Xie SS. Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft [ J ]. Transplant Proc, 2003, 35 ( 8 ):3 165-3 166.
  • 7Liu H, Mao N, Hou C, et al. Protective effect of human CD40-Ig fusion protein in a murine model of acute gTaft-versus-host disease[J]. Chin Med J (Engl), 2001, 114 (7):685 - 689.
  • 8Tone M, Tone Y, Fairchild PJ, et al. Regulation of CD40 function by its isoforms generated through alternative splicing [J]. Proc Natl Acad Sci USA, 2001, 98 (4):1751-1756.
  • 9Li M, Su ZG, Janson JC. In vitro protein refolding by chromatographic procedures [ J ]. Protein Expr Purif, 2004,33 (1): 1-10.
  • 10Contin C, Pitard V, Delmas Y, et al. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients [J]. Immunology, 2003, 110 (1): 131 - 140.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部